GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis

Associations between bladder cancer risk and NAT2 and GSTM1 polymorphisms have emerged as some of the most consistent findings in the genetic epidemiology of common metabolic polymorphisms and cancer, but their interaction with tobacco use, intensity and duration remain unclear. In a New England pop...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Moore, L.E., Baris, D.R., Figueroa, J.D., Garcia-Closas, M., Karagas, M.R., Schwenn, M.R., Johnson, A.T., Lubin, J.H., Hein, D.W., Dagnall, C.L., Colt, J.S., Kida, M., Jones, M.A., Schned, A.R., Cherala, S.S., Chanock, S.J., Cantor, K.P., Silverman, D.T., Rothman, N.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2011
Matèries:
Molecular Epidemiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3026839/
https://ncbi.nlm.nih.gov/pubmed/21037224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgq223
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars